STOK - CIK 0001623526
Stoke Therapeutics, Inc. (STOK) reported revenue of $184.42M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $184.42M | +404.5% |
| FY 2024 | $36.55M | +316.3% |
| FY 2023 | $8.78M | -29.2% |
| FY 2022 | $12.40M | - |
Stoke Therapeutics, Inc. (STOK) reported revenue of $184.42M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.